FDAFDA · Food and drugs·Recall number D-0921-2017
Venlafaxine Hydrochloride Extended-Release Capsules USP, 75 mg, packaged in a) 30-count bottles (NDC 52343-132-30) and b) 90-count bottles (NDC 52343-132-90), Rx only, Distributed by: Lucid Pharma LLC, 2 Tower Center Blvd, Suite-1101-B, East Brunswick, NJ 08816 USA.
Published June 28, 2017 · Recall initiated: June 1, 2017
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Tablet/Capsules Specifications: pharmacists complaints for bottles containing melted capsules.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Manufacturer
- Lucid Pharma LLC
- Distributor
- Nationwide in the USA
- Lot
- Lot #: a) V17516045-A, Exp 08/18; b) V17516047-A 09/18
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.